DBV Technologies | Fremdkapital





Fremdkapital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.04B 13.75M 2025-09
BioCryst Pharmaceuticals USD 194.37M 48.43M 2025-09
BioMarin Pharmaceutical USD 596.66M 501K 2025-09
DBV Technologies USD 0 0 2025-03
Esperion Therapeutics USD 262.48M 235.95M 2024-06
Galectin Therapeutics USD 93.42M 9.08M 2024-06
Halozyme Therapeutics USD 800.07M 709.03M 2025-09
Incyte USD 35.37M 3.61M 2025-09
Insmed USD 539.72M 21.23M 2025-09
Ionis Pharmaceuticals USD 28.78M 596.71M 2025-09
Neurocrine Biosciences USD 169.5M 500K 2023-03
PTC Therapeutics USD 1.84B 298.68M 2025-09
Sarepta Therapeutics USD 1.04B 104.31M 2025-09
Ultragenyx Pharmaceutical USD 782.75M 11.3M 2025-06
United Therapeutics USD 100M 100M 2024-06


DBV Technologies Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.